For release at 6:30 a.m.
DUSA Pharmaceuticals, Inc.® to Webcast
Annual Meeting of Shareholders
Thursday, June 14th, 11:00am EDT
Wilmington, Mass. – June 7, 2012 - DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that it will host a live audio webcast of its Annual Meeting of Shareholders at 11:00am EDT on Thursday, June 14, 2012.
Interested parties are invited to listen to the presentation and may access the webcast here or by visiting our website at www.dusapharma.com. A replay of the meeting will be available on the DUSA website later in the day. To access the replay, visit the Investors section of Company’s website and click on the Webcast link.
About DUSA Pharmaceuticals
DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform. Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% plus blue light illumination using DUSA’s BLU-U® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.
For further information contact:
Chad Rubin, The Trout Group LLC, 646-378-2947